- Volume is elevated versus the 13-week average, confirming attention.
0013
HKG
Week ended 07 Aug 2026
Weekly Investor Report
HUTCHMED (China) Limited · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
19.48 HKD
10.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -6.1% below the Trend Line and sits at 29.1% of its 52-week range. The latest completed week returned 10.0%, after a 10.0% four-week move. The latest news-sentiment score is 53/100.
Setup score
37
out of 100
Latest Close
19.48 HKD
7 Aug 2026
1W Return
10.0%
latest completed week
4W Return
10.0%
short-term follow-through
12W Return
-2.1%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
1.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
10.0%
Latest completed week; four-week move 10.0%.
Indicator stack
11/50
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
53/100
13 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -6.1% below the Trend Line and sits at 29.1% of its 52-week range. The latest completed week returned 10.0%, after a 10.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0312-week average 0.12
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 10.0% over four weeks, -2.1% over 12 weeks, and -17.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.34Latest activity-pressure read.
Pressure change71.8%Four-week change in activity pressure.
Leadership-11.10Latest relative-leadership reading.
RS change34.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 13 relevant articles.
3 positive · 9 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-32.4%Distance below the 52-week high.
13-week volatility5.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher7 of 2619 weeks finished lower.
Best week+14.0%Week of 3 Jul.
Worst week-11.5%Week of 24 Apr.
Latest week+10.0%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains3
Flat weeks0
Modest losses15
Sharp losses4
Recent vol5.7%13-week weekly-return volatility.
Base vol5.3%52-week weekly-return volatility.
Up/down split18/33Count of positive and negative weeks in the 52-week window.
Average skew5.4% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorHK Healthcare
4-week rank16 / 100
Group average4.4%
Trend breadth12.0%
Trend12.0%active weekly trend signals
MD32.0%positive activity pressure
RS19.0%positive relative leadership
Four-week leaders
IndustryHK Drug Manufacturers - Specialty & Generic
4-week rank4 / 50
Group average-0.2%
Trend breadth8.0%
Trend8.0%active weekly trend signals
MD38.0%positive activity pressure
RS18.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape31/100
Trend, activity pressure, participation, and risk combine to a 31/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.03; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 13 relevant articles.
Hutchmed returns to revenue growth in first half of 2026 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 19.48 HKD | 10.0% | 20.75 HKD | 24.87 HKD | -0.34 | -11.10 | 22.5M | Off |
| 31 Jul 2026 | 17.71 HKD | 1.0% | 20.87 HKD | 24.89 HKD | -0.74 | -20.19 | 11.1M | Off |
| 24 Jul 2026 | 17.54 HKD | 0.5% | 20.98 HKD | 24.93 HKD | -0.87 | -18.83 | 13.8M | Off |
| 17 Jul 2026 | 17.45 HKD | -1.5% | 21.09 HKD | 24.97 HKD | -1.01 | -18.65 | 21.3M | Off |
| 10 Jul 2026 | 17.71 HKD | -1.9% | 21.20 HKD | 24.99 HKD | -1.21 | -16.87 | 17.3M | Off |
| 3 Jul 2026 | 18.05 HKD | 14.0% | 21.32 HKD | 25.01 HKD | -1.38 | -12.90 | 6.7M | Off |
| 26 Jun 2026 | 15.83 HKD | -3.6% | 21.45 HKD | 25.01 HKD | -1.52 | -21.79 | 3.4M | Off |
| 19 Jun 2026 | 16.42 HKD | -5.4% | 21.68 HKD | 25.03 HKD | -1.48 | -23.58 | 12.0M | Off |
| 12 Jun 2026 | 17.36 HKD | -1.6% | 21.86 HKD | 25.04 HKD | -1.44 | -22.33 | 3.2M | Off |
| 5 Jun 2026 | 17.64 HKD | -3.7% | 22.07 HKD | 25.06 HKD | -1.26 | -22.56 | 4.1M | Off |
| 29 May 2026 | 18.32 HKD | -4.4% | 22.27 HKD | 25.07 HKD | -1.12 | -20.79 | 22.5M | Off |
| 22 May 2026 | 19.17 HKD | -3.6% | 22.44 HKD | 25.08 HKD | -1.03 | -18.89 | 21.4M | Off |
| 15 May 2026 | 19.89 HKD | -5.3% | 22.57 HKD | 25.08 HKD | -0.75 | -17.27 | 34.2M | Off |
| 8 May 2026 | 21.00 HKD | -0.7% | 22.70 HKD | 25.09 HKD | -0.21 | -14.33 | 17.9M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.